Protocol 1: Conservative foundation (beginners) Goal: Gentle immune modulation with minimal risk Components: Thymosin alpha-1: 1.6 mg subcutaneously, twice weekly BPC-157: 250 mcg subcutaneously, once daily (abdominal injection for gut support) Schedule: Monday and Thursday: Thymosin alpha-1 Daily: BPC-157 in the morning Duration: 8 weeks on, 4 weeks off Monitoring: Baseline labs before starting, repeat at week 4 and week 8
Also, GHK-Cus role in supporting epithelial barrier proteins makes it of interest for mucosal healing research
Testosterone Therapy Some men start testosterone therapy thinking it will solve all their hormonal issues, only to find their symptoms persistor even worsen
Those are GLP-1 receptor agonists, not growth hormone peptides
Reception, accommodation at the lodge
This study was based on the potent anti-inflammatory effects of BPC-157